Screener
Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$53.09M-74.7% | -$46.06M-37.2% | -$42.22M-22.2% | -$43.78M-44.1% | -$30.39M+1.9% | ||
| $119K-7.0% | $187K+61.2% | $43K-54.7% | $132K+40.4% | $128K+45.5% | ||
| $10.15M+132% | $4.27M-32.5% | $4.25M-24.5% | $4.69M-18.0% | $4.38M-10.8% | ||
| -$45.99M-4.6% | -$38.33M-45.8% | -$34.53M-27.8% | -$29.88M-8.4% | -$43.98M-87.2% | ||
| $4.53M+110% | -$162.18M-41.7% | $17.27M-62.4% | —— | -$45.08M-124% | ||
| $45.7M+20,487% | $213.55M-12.6% | $41K-55.4% | -$2.52M-116% | $222K-97.5% | ||
| $4.25M+105% | —— | -$17.21M-191% | —— | -$88.84M-155% |
FAQ
- How much cash does Olema Pharmaceuticals, Inc. generate?
- Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
- Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.